Madrigal Pharmaceuticals, Inc.
DE ˙ DB ˙ US5588681057
413,00 € ↓ -12,70 (-2,98%)
2026-06-01
DEL PRIS
SecurityDE:YDO1 / Madrigal Pharmaceuticals, Inc.
InstitutionFmr Llc
Latest Disclosed Ownership34,241 shares
Ownership 0.22%
Fmr Llc ownership in YDO1 / Madrigal Pharmaceuticals, Inc.

2019-02-13 - Fmr Llc has filed an SC 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 34,241 shares of Madrigal Pharmaceuticals, Inc. (DE:YDO1). This represents 0.222 percent ownership of the company. In their previous filing dated 2018-02-13 , Fmr Llc had reported owning 717,125 shares, indicating a decrease of -95.23 percent.

Institutional Ownership: 13D/G Filings

This table shows a history of the 13D/G filings made by the investor and/or investor group. Note that the share values in this table are not directly comparable to any numbers shown in the 13F table (if any).

File
Date		Effective
Date		Form Prev
Shares		 Latest
Shares		 ΔShares
(Percent)		 Ownership
(Percent)		 ΔOwnership
(Percent)
2019-02-13 2019-02-13 13G/A 717,125 34,241 -95.23 0.22 -95.60
2018-02-13 2018-02-13 13G 717,125 5.04
2013-07-10 2013-07-10 13G/A 2,068,829 2.99
2013-02-14 2013-02-14 13G/A 7,203,589 10.46
2012-12-10 2012-12-10 13G 6,493,800 10.49

Important Note: One of the primary uses of the 13D/G filings is to evaluate the ability of a firm to control a company (ie, the "beneficial ownership"). To that end, firms are required to report not just direct holdings in companies, but indirect holdings that they control. For investment firms, these indirect holdings can include shares in funds they manage, advisory accounts, and in the case of activist campaigns, pledged votes. Therefore, share counts listed in 13D/G filings can differ significantly than share counts listed in 13F filings.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 511,728 72,330 16.46 267,874 4.69 0.0028
2026-02-17 2025-12-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 439,398 38,262 9.54 255,879 39.08 0.0130
2025-11-13 2025-09-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 401,136 -44,203 -9.93 183,985 36.51 0.0096
2025-08-14 2025-06-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 445,339 -206,760 -31.71 134,777 -37.60 0.0076
2025-05-12 2025-03-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 652,099 -215,751 -24.86 215,995 -19.34 0.0138
2025-02-13 2024-12-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 867,850 84,305 10.76 267,792 61.05 0.0160
2024-11-13 2024-09-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 783,545 -5,458 -0.69 166,284 -24.77 0.0101
2024-08-13 2024-06-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 789,003 75,089 10.52 221,047 15.95 0.0141
2024-05-13 2024-03-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 713,914 88,749 14.20 190,644 31.80 0.0128
2024-02-13 2023-12-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 625,165 184,785 41.96 144,651 124.92 0.0111
2023-11-13 2023-09-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 440,380 91,337 26.17 64,313 -20.23 0.0056
2023-08-11 2023-06-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 349,043 86,600 33.00 80,629 26.82 0.0068
2023-08-11 2023-03-31 13F/A-1 MADRIGAL PHARMACEUTICALS COM 558868105 262,443 63,953 32.22 63,579 10.36 0.0058
2023-05-11 2023-03-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 262,443 63,953 63,579 0.0058
2023-02-13 2022-12-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 198,490 34,716 21.20 57,612 441.25 0.0057
2022-11-10 2022-09-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 163,774 160 0.10 10,644 -9.11 0.0011
2022-08-12 2022-06-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 163,614 -505 -0.31 11,711 -27.27 0.0012
2022-05-13 2022-03-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 164,119 -2,421 -1.45 16,103 14.10 0.0013
2022-02-14 2021-12-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 166,540 0 0.00 14,113 6.21 0.0010
2022-02-14 2021-09-30 13F/A-1 MADRIGAL PHARMACEUTICALS COM 558868105 166,540 0 0.00 13,288 -18.09 0.0011
2021-11-15 2021-09-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 166,540 0 13,288 0.0011
2021-08-13 2021-06-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 166,540 -12,100 -6.77 16,223 -22.36 0.0013
2021-05-14 2021-03-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 178,640 77,978 77.47 20,896 86.72 0.0018
2021-02-08 2020-12-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 100,662 66,421 193.98 11,191 175.30 0.0010
2020-11-13 2020-09-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 34,241 0 0.00 4,065 4.82 0.0004
2020-08-24 2020-06-30 13F/A-1 MADRIGAL PHARMACEUTICALS COM 558868105 34,241 0 0.00 3,878 69.64 0.0004
2020-08-13 2020-06-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 34,241 0 3,878 95.2711
2020-05-14 2020-03-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 34,241 0 0.00 2,286 -26.73 0.0003
2020-02-07 2019-12-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 34,241 0 0.00 3,120 5.69 0.0003
2019-11-13 2019-09-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 34,241 0 0.00 2,952 -17.75 0.0004
2019-08-13 2019-06-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 34,241 0 0.00 3,589 -16.32 0.0004
2019-05-13 2019-03-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 34,241 0 0.00 4,289 11.11 0.0005
2019-02-13 2018-12-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 34,241 -18,739 -35.37 3,860 -65.97 0.0005
2018-11-09 2018-09-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 52,980 -10,594 -16.66 11,344 -36.20 0.0013
2018-08-10 2018-06-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 63,574 -157,257 -71.21 17,781 -31.06 0.0021
2018-05-14 2018-03-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 220,831 -496,294 -69.21 25,791 -60.82 0.0031
2018-02-12 2017-12-31 13F MADRIGAL PHARMACEUTICALS COM 558868105 717,125 163,555 29.55 65,825 164.36 0.0077
2017-11-13 2017-09-30 13F MADRIGAL PHARMACEUTICALS COM 558868105 553,570 553,570 24,900 0.0030
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.